|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2005-3-10
|
|
pubmed:abstractText |
Recent data suggest that extended lymph node dissection in prostate cancer may be necessary for accurate staging. With limited lymph node dissection apparently node negative cases might be under staged. We determined the impact that the number of lymph nodes removed at radical retropubic prostatectomy (RRP) has on cancer progression and cause specific survival in pTXNO cases.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
173
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1121-5
|
|
pubmed:meshHeading |
pubmed-meshheading:15758719-Adult,
pubmed-meshheading:15758719-Aged,
pubmed-meshheading:15758719-Aged, 80 and over,
pubmed-meshheading:15758719-Cause of Death,
pubmed-meshheading:15758719-Disease Progression,
pubmed-meshheading:15758719-Disease-Free Survival,
pubmed-meshheading:15758719-Follow-Up Studies,
pubmed-meshheading:15758719-Humans,
pubmed-meshheading:15758719-Lymph Node Excision,
pubmed-meshheading:15758719-Lymph Nodes,
pubmed-meshheading:15758719-Male,
pubmed-meshheading:15758719-Middle Aged,
pubmed-meshheading:15758719-Neoplasm Staging,
pubmed-meshheading:15758719-Prostate-Specific Antigen,
pubmed-meshheading:15758719-Prostatectomy,
pubmed-meshheading:15758719-Prostatic Neoplasms,
pubmed-meshheading:15758719-Retrospective Studies,
pubmed-meshheading:15758719-Survival Rate,
pubmed-meshheading:15758719-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
|
|
pubmed:affiliation |
Department of Urology, Mayo Clinic, Rochester, Minnesota 55901, USA.
|
|
pubmed:publicationType |
Journal Article
|
